Nemaura Medical Inc. Secures 10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
NMRDDelisted Stock | USD 0.93 0.01 1.06% |
About 61% of Nemaura Medical's investor base is looking to short. The analysis of overall sentiment of trading Nemaura Medical pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Nemaura Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Nemaura Medical stock news signals to limit their universe of possible portfolio assets.
Nemaura Medical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Nemaura daily returns and investor perception about the current price of Nemaura Medical as well as its diversification or hedging effects on your existing portfolios.
Nemaura |
Loughborough, UK, Nov. 21, 2023 -- Nemaura Medical Inc. , developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce the execution of a strategic agreement for a 10 million credit facility which is expected to support the Companys strategic growth plans. Recognizing the challenges associated with equity sales, particularly in the small-cap landscape on the Nasdaq, Nemaura Medi
Read at finance.yahoo.com
Nemaura Medical Fundamental Analysis
We analyze Nemaura Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nemaura Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nemaura Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Nemaura Medical is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Nemaura Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nemaura Medical pink sheet to make a market-neutral strategy. Peer analysis of Nemaura Medical could also be used in its relative valuation, which is a method of valuing Nemaura Medical by comparing valuation metrics with similar companies.
Peers
Nemaura Medical Related Equities
MOVE | Movano | 6.20 | ||||
NPCE | Neuropace | 3.50 | ||||
CVRX | CVRx | 3.33 | ||||
AORT | Artivion | 1.82 | ||||
OFIX | Orthofix Medical | 1.40 | ||||
ELMD | Electromed | 0.91 | ||||
SRDX | SurModics | 0.40 | ||||
BJDX | Bluejay Diagnostics | 1.54 | ||||
NVNO | EnVVeno Medical | 1.58 | ||||
MODD | Modular Medical | 2.80 | ||||
SSKN | STRATA Skin | 5.25 | ||||
NXL | Nexalin Technology | 14.05 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |